Event

Journal Club - Early Phase Clinical Trials

21 July, 2011, 3 PM-4 30 PM

Add to:

Chair: Alun Bedding, Director, GlaxoSmithKline

Speaker: Timothy H Montague, GlaxoSmithKline
Sequential design approaches for bioequivalence studies with crossover designs
Co-authors: Diane Potvin, Charles E. DiLiberti, Walter W. Hauck, Alan F. Parr, Donald J. Schuirmann and Robert A. Smith
Pharmaceutical Statistics, Volume 7, Issue 4, October/December 2008, Pages: 245–262

Plus information from:
Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’

(Subsequently published in: Pharmaceutical Statistics, Volume 11, Issue 1, pages 8–13, January/February 2012)
Abstract | Paper⁺ | Slides

Speaker: Ileana Baldi, Unit of Cancer Epidemiology, CeRMS and CPO Piemonte, University of Turin
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas
Co-authors: Sarah Zohar, Guido Forni, Franco Merletti, Giuseppe Masucci and Dario Gregori
Pharmaceutical Statistics, Volume 10, Issue 3, pages 218–226, May/June 2011
Abstract | Paper⁺ | Slides

⁺ Papers available to view from 14^th July 2011 to 11^th August 2011.

For a flier advertising the event, please click here.

Upcoming Events

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

5 November, 2020, 2 PM-4 PM

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

PSI Journal Club: Bayesian Methods

17 November, 2020, 4 PM-5 PM

Please join us to hear Jingjing Ye (BeiGene) and Amy LaLonde (Eli Lilly) present their recent work. The webinar will be chaired by Bruno Boulanger (PharmaLex).

Senior Principal / Principal Biostatistician

Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.